{domain:"www.qualitydigest.com",server:"169.47.211.87"} Skip to main content

User account menu
Main navigation
  • Topics
    • Customer Care
    • FDA Compliance
    • Healthcare
    • Innovation
    • Lean
    • Management
    • Metrology
    • Operations
    • Risk Management
    • Six Sigma
    • Standards
    • Statistics
    • Supply Chain
    • Sustainability
    • Training
  • Videos/Webinars
    • All videos
    • Product Demos
    • Webinars
  • Advertise
    • Advertise
    • Submit B2B Press Release
    • Write for us
  • Metrology Hub
  • Training
  • Subscribe
  • Log in
Mobile Menu
  • Home
  • Topics
    • 3D Metrology-CMSC
    • Customer Care
    • FDA Compliance
    • Healthcare
    • Innovation
    • Lean
    • Management
    • Metrology
    • Operations
    • Risk Management
    • Six Sigma
    • Standards
    • Statistics
    • Supply Chain
    • Sustainability
    • Training
  • Login / Subscribe
  • More...
    • All Features
    • All News
    • All Videos
    • Contact
    • Training

Generic Drugs Can Lead to Lower Prices

Quality Digest
Mon, 07/24/2006 - 22:00
  • Comment
  • RSS

Social Sharing block

  • Print
Body
Authorized generic drugs can lead to lower medicine prices and overall savings to the health care system, according to a new study commissioned by the Pharmaceutical Research and Manufacturers of America and prepared by IMS Consulting. An authorized generic is a drug that is distributed by a generics company with permission from the brand-name company. It can compete in the market during the 180-day exclusivity period awarded to generics companies that succeed in breaking a brand drug’s patent before it expires.

The investigation examined case studies with and without generics, and found that with an authorized generic on the market during the exclusivity period, discounts to brand medications were greater—on average, 15.8 percentage points greater—than instances when a generics company didn’t face competition from an authorized generic. It also found that even after the 180-day exclusivity period, authorized generics help save the health care system $212.8 million across the nine case studies examined during the six-month exclusivity period.

 …

Want to continue?
Log in or create a FREE account.
Enter your username or email address
Enter the password that accompanies your username.
By logging in you agree to receive communication from Quality Digest. Privacy Policy.
Create a FREE account
Forgot My Password

Add new comment

Image CAPTCHA
Enter the characters shown in the image.
Please login to comment.
      

© 2025 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute Inc.

footer
  • Home
  • Print QD: 1995-2008
  • Print QD: 2008-2009
  • Videos
  • Privacy Policy
  • Write for us
footer second menu
  • Subscribe to Quality Digest
  • About Us
  • Contact Us